Form 4 Tracker
Patricia Carr

SVP, Chief Accounting Officer · 3 filings · Latest: Mar 5, 2026

Jazz Pharmaceuticals plc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
JAZZ
Patricia CarrSVP, Chief Accounting OfficerMar 9, 2026
Sale
$182.941,287$235.4K6,512
JAZZ
PATRICIA CARR—Mar 9, 2026
Proposed Sale
$182.941,287$235.4K—
JAZZ
Carr Patricia—Mar 5, 2026
Proposed Sale
$188.692,723$513.8K—
JAZZ
Patricia CarrSVP, Chief Accounting OfficerFeb 27, 2026
Sale
$190.911,117$213.2K9,235
JAZZ
Patricia CarrSVP, Chief Accounting OfficerFeb 26, 2026
Sale
$194.111,253$243.2K10,352
JAZZ
PATRICIA CARR—Feb 27, 2026
Proposed Sale
$190.911,117$213.2K—
JAZZ
Carr Patricia—Feb 26, 2026
Proposed Sale
$196.832,370$466.5K—
JAZZ
PATRICIA CARR—Dec 5, 2025
Proposed Sale
$171.204,660$797.8K—
JAZZ
PATRICIA CARR—Nov 18, 2025
Proposed Sale
$182.065,319$968.4K—
JAZZ
Carr Patricia—Mar 10, 2025
Proposed Sale
$137.811,140$157.1K—
JAZZ
Carr Patricia—Feb 28, 2025
Proposed Sale
$143.30773$110.8K—
JAZZ
Carr Patricia—Mar 5, 2025
Proposed Sale
$139.004,114$571.8K—
JAZZ
Carr Patricia—Feb 27, 2025
Proposed Sale
$144.424,813$695.1K—
JAZZ
Carr Patricia—Dec 2, 2024
Proposed Sale
$122.4953$6.5K—